A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation | MicrobiomeTrials← Back to trialsNCT07814417
A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2028-11
Enrollment target: 50 participants Other microbiome trials you might be interested in
Prostate CancerLeukemiaBreast CancerMelanomaColorectal Cancer
Study Description:
ELEA is an observational cohort study that will collect exposure information and biospecimens from t…
Bethesda, United StatesCompleted Dec 23, 2027
Colorectal Adenocarcinoma
Colorectal cancer is one of the most common cancers worldwide. Although surgery and drug treatments have improved, some …
Nice, FranceEst. completion Oct 1, 2027
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell CarcinomaStage IIB Anal Cancer AJCC v8Stage III Anal Cancer AJCC v8
This phase III trial investigates how well nivolumab after combined modality therapy works in treating patients with hig…
Birmingham, United StatesEst. completion Dec 31, 2027